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Background: The advent of double-balloon enteroscopy has enabled more accurate diagnosis and treatment of
small bowel disorders. Single-balloon enteroscopy permits visualization of the entire small intestine less often than
does double-balloon enteroscopy. However, the relative clinical advantages of the 2 methods remain controversial.
This study therefore aimed to identify the indications for and therapeutic impact of performing single-balloon
enteroscopy.
Methods: We retrospectively reviewed prospectively collected data from adults who underwent single-balloon
enteroscopy from January 2007 through November 2011 and analyzed their baseline characteristics, endoscopic
findings, pathological diagnoses, and clinical outcomes.
Results: A total of 145 procedures were performed in 116 patients with a mean age of 58.1 ± 17.7 years (range,
18–89 years). The most common indications for performing single-balloon enteroscopy were overt gastrointestinal
(GI) bleeding, chronic diarrhea, and occult GI bleeding, accounting for 57.9%, 12.4%, and 9.7% of the patients,
respectively. The area of interest was achieved in 80.7% of the cases, with a 5.5% rate of technical failure. An overall
positive finding was detected in 65.5% of the cases, of which 33.8% were ulcers and erosions; 8.3%, masses; and
3.4%, angiodysplasia. The diagnostic yields were 42.9%, 52.4%, 78.6%, 50.0%, and 25.0% for patients with overt
GI bleeding, occult GI bleeding, abdominal pain, chronic diarrhea, and abnormal imaging results, respectively.
Therapeutic procedures were performed in 11% of patients with GI bleeding and achieved a therapeutic yield of
14.6% with a minor complication rate of 11.7%.
Conclusions: Single-balloon enteroscopy was effective for the diagnosis and treatment of small bowel disorders,
especially in patients who presented with abdominal pain, GI bleeding, or focal abnormalities on imaging scans.
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The inaccessibility of the small intestine has traditionally
made it the “final frontier” for gastroenterologists. However,
the past decade has seen the development of 4 nonsurgical,
push-and-pull flexible endoscopy techniques: balloon-
assisted enteroscopy using 2 balloons (double-balloon* Correspondence: kaiyjr@gmail.com
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distribution, and reproduction in any mediumenteroscopy [DBE]) or 1 balloon (single-balloon enteroscopy
[SBE]), balloon-guided enteroscopy (BGE), and the newly
developed spiral enteroscopy (SE), which pleats the small
bowel via rotation of an overtube. DBE, the first balloon-
assisted enteroscopy technique developed, was introduced
in 2001 [1]. It requires a significant learning curve and a
great deal of experience on the part of the endoscopists who
perform the procedure, and the procedure itself is cumber-
some. To overcome these limitations, SBE was developed by
removing the balloon on the enteroscope and using the
hook/suction-and-pull technique in its place; the resultingntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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easier to handle. There have been several reports of signifi-
cant differences in the total endoscopy rate between DBE
and SBE. DBE achieves total enteroscopy at a 3-fold higher
rate than SBE or SE [2-5]. However, the contributions of
total enteroscopy to the diagnostic yield and the manage-
ment of small bowel disease remain controversial [6,7].
SBE was developed by Olympus, Inc. (Tokyo, Japan) in
2006, and the insertion technique was notably well-
established [8]. However, only limited data on SBE are avai-
lable. To our knowledge, only a few published studies have
compared SBE and DBE directly. Although the insertion
depth is smaller for SBE than for DBE, the diagnostic and
therapeutic yields of these techniques do not greatly differ.
Therefore, the insertion depth or examination of the entire
small intestine (total enteroscopy) might not contribute to
the diagnostic and therapeutic yields [6,9-11]. The primary
objective of this retrospective study was to evaluate the cli-
nical utility of SBE in patients with suspected small bowel
disease according to the different indications for performing
the procedure.
Methods
This retrospective review was performed at a large endos-
copy center within a university-based hospital using data
from January 2007 through November 2011. The present
study was approved by the Siriraj Institutional Review
Board (SIRB). Most of the procedures were performed by a
few dedicated gastroenterologists, each of whom had
performed more than 30 SBEs. The electronic and paper-
based medical records were reviewed. The patients’ baseline
characteristics such as their demographic data, indications
for enteroscopy, procedure details, anesthetic methods, im-
mediate and short-term complications, pathological re-
ports, and treatments, were analyzed. The indications for
performing enteroscopy included overt gastrointestinal (GI)
bleeding; occult GI bleeding; anemia; abnormalities on
computed tomography (CT) or magnetic resonance im-
aging (MRI) scans or in the results of small bowel barium
studies (simple barium study of the small intestine, not
enteroclysis); abdominal pain; and chronic diarrhea. Overt
bleeding was defined as obvious bloody content on initial
presentation with negative esophagogastroduodenoscopy
and colonoscopy results. Occult bleeding was defined as a
positive guaiac fecal occult blood test result without obvi-
ous bleeding. Anemia was defined as a low hemoglobin
level (<13 mg/dL for men or <12 mg/dL for women) with-
out evidence of overt or occult GI bleeding. Enteroscopy
was performed in patients with abdominal pain if the eti-
ology of the pain was unclear; this included cases of
suspected chronic inflammatory bowel disease or small in-
testinal infection. Chronic diarrhea was defined as diarrhea
lasting for >4 weeks. Informed consent was obtained from
all the patients. All procedures were performed in theendoscopic suite with full anesthetic monitoring. SBE (SIF-
Q180, Olympus Optical, Tokyo, Japan) was performed with
the patient under total intravenous anesthesia (TIVA) or
general anesthesia (GA) in all cases. The insertion depth is
not measured in centimeters at our institute; therefore, in
our study, the performing endoscopist estimated the inser-
tion depth at the end of the procedure in terms of the re-
gion to which the endoscope was inserted, such as the
proximal jejunum, mid-jejunum, distal jejunum, proximal
ileum, mid-ileum, or distal ileum. Total enteroscopy refers
to bidirectional endoscopy in which the enteroscope is
passed during the second procedure through the site
marked by tattooing during the first procedure. The pro-
cedure time extended from the time at which the scope
was passed through the mouth until the time at which it
was completely withdrawn from the mouth (antegrade
route) or from the time at which the scope was passed
through the anus to the time at which it was completely
withdrawn from the anus (retrograde route). A procedure
was considered a failure when it was terminated because
the endoscopist could not advance the enteroscope deeper
than the proximal jejunum owing to altered or abnormal
anatomy not identified before the procedure. The areas of
interest achieved were recorded. The diagnostic yield was
defined as the percentage of procedures that produced
either a definitive diagnosis or findings that could explain
the clinical symptoms. Clinical success was defined as the
effectiveness of enteroscopy at obtaining a definitive diag-
nosis and/or treating lesions or, in cases of overt GI bleed-
ing, at preventing further bleeding until the last follow-up
visit. All of the data were recorded and analyzed using SPSS
version 13.0. The results were summarized using standard
methods. The parametric data were reported as percen-
tages. The nonparametric continuous data were expressed
as the mean ± SD. The differences between the nonpara-
metric unpaired continuous data were analyzed using the
chi-square or Fischer’s exact test. A p value of less than 0.05
was defined as significant.
Results
A total of 145 consecutive SBE procedures were performed
in the 116 patients who included in our study. The mean
age of the patients was 58.1 ± 17.7 years (range, 18–89 years),
and the male-to-female ratio was 1:1. Of the patients, 22%
underwent a retrograde procedure, whereas 77% underwent
an antegrade procedure. Only 1 patient underwent a bidirec-
tional procedure in a single session, although another 15 bi-
directional procedures were performed sequentially. Of
these 15, 8 were completed within 7 days after the first pro-
cedure. The average time between the 2 procedures was
11.3 days. The indications for enteroscopy were overt GI
bleeding, occult GI bleeding, chronic diarrhea, abdominal
pain, and abnormal imaging results in 57.9%, 22.1%, 12.4%,
8.3%, and 5.5% of procedures, respectively. All patients
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enteroscopy (VCE) in 46.2% of the patients and imaging ex-
aminations such as CT, MRI, or barium studies in 23.4% of
the patients, before undergoing SBE. Fluoroscopy was used
in 71.7% of the procedures. Of the patients, 12.4%, 55.8%,
33.1%, and 0.7% were classified as American Society of An-
esthesiologists (ASA) class I, II, III, and IV, respectively. Dur-
ing the procedure, 40% of the patients were maintained
under TIVA and 59.3% under GA. Total enteroscopy was
achieved in 1 (6.23%) of 16 attempts. Eight procedures
(5.5%) were considered failures. The mean ± SD procedure
duration was 82.4 ± 43.2 min for all procedures, 81.8 ±
41.2 min for antegrade procedures, and 78.3 ± 34.7 min for
retrograde procedures. The areas of interest were achieved
in 80.7% of the patients, and positive findings were detected
in 60.0%. However, the positive findings in this study were
further classified on the basis of their relevance to the clin-
ical manifestations as definitive diagnoses, associated posi-
tive findings, and incidental diagnoses. A definitive diagnosis
was obtained in 32.4% of the patients and an overall diagno-
sis (either a definitive diagnosis or an associated positive
finding) in 47.6%. Therapeutic interventions were performed
in only 16 patients (11.0%). No serious complications oc-
curred in the cases reviewed for this study.
The most common enteroscopic findings obtained via
both the antegrade and retrograde routes of insertion were
erosions and ulcers, including angiodysplasia. The significant
findings obtained via the antegrade route were Dieulafoy’s
lesions, varices, polyps, and masses, as shown in Table 1.Table 1 Endoscopic findings according to the route of
insertion
Finding Total Antegrade Retrograde
(n = 145) (n = 112) (n = 34)
n (%) n (%) n (%)
Angiodysplasia 5 (3.4) 4 (3.6) 1 (2.9)
Ulcer 26 (17.9) 17 (15.2) 9 (26.4)
Erosion 23 (15.9) 21 (18.8) 2 (5.9)
Stricture 6 (4.1) 4 (3.6) 2 (5.9)
Polyp 8 (5.5) 8 (7.1) 0
Mass 12 (8.3) 12 (10.7) 0
Irregular/erythematous mucosa 26 (17.9) 25 (22.3) 1 (2.9)
Blood stain 5 (3.4) 4 (3.6) 1 (2.9)
Lipoma 1 (0.7) 1 (0.9) 0
Villous atrophy 7 (9.3) 7 (6.3) 0
Diverticulum 4 (2.8) 4 (3.6) 0
Dieulafoy’s lesion 5 (3.4) 5 (4.5) 0
Varix 2 (1.4) 2 (1.8) 0
Hemangioma 1 (0.7) 1 (0.9) 0
Lymphangiectasia 14 (9.7) 14 (12.5) 0The patients’ demographic data, enteroscopic procedure
details, and positive findings were analyzed according to the
clinical manifestations, as shown in Table 2. The diagnostic
yields were 42.9%, 52.4%, 78.6%, 50.0%, and 25.0% for pa-
tients with overt GI bleeding, occult GI bleeding, abdo-
minal pain, chronic diarrhea, and abnormalities on imaging
scans, respectively.
Findings
The most common indication (72.4% of procedures) for
performing enteroscopy in this study was obscure bleeding
(both overt and occult bleeding). The enteroscopic findings
are shown in Table 2. The most common endoscopic find-
ings obtained in this study were ulcers and erosions (33.8%),
and the second-most common finding was nonspecific
changes such as mucosal irregularity or erythematous mu-
cosa. Angiodysplasia was detected in only 3.4% of the pa-
tients in this study. Only 67 patients in this study underwent
VCE. The enteroscopic finding was consistent with the VCE
finding in 33 (48.5%) of 67patients.
Overt GI bleeding
A total of 84 patients underwent SBE for investigation
of overt GI bleeding. The most common enteroscopic
findings were erosions and ulcers (32.2%), followed by
vascular lesions (13.2%) (consisting of Dieulafoy’s le-
sions [6.0%], angiodysplasia [4.8%], and varices [2.4%])
and tumors (9.5%). The diagnostic yield of SBE for overt
GI bleeding was 42.9%. The definitive causes of overt
GI bleeding remained unidentified in approximately
57.1% of the cases. However, we followed up the pa-
tients in this subgroup and found that these patients ex-
perienced no recurrent bleeding during the mean
follow-up period of 46.15 weeks. Therapeutic interven-
tions were performed during 11 procedures and were
successful in all but 1 patient (who experienced recur-
rent bleeding). The outcomes in this group are also
shown in Table 2 The clinical success rate of the proce-
dures in this group was low (41.7%); as erosions and ul-
cers were the most common indications for performing
the procedures, we suspected that the low success rate
might have been because of healing of the lesions be-
tween initial presentation and endoscopy. Therefore, we
identified the time to enteroscopy (defined as the inter-
val from the onset of clinical signs to the performance
of the procedure), which was 49.3 ± 104.9 days overall,
and compared the mean time to enteroscopy between
the patients in which SBE was clinically successful and
those in which it was not. The time to enteroscopy was
75.9 ± 25.6 days for the first group but 29.5 ± 6.6 days in
the second group. However, this difference was not sta-
tistically significant (p = 0.08). Both VCE and SBE were
performed in 60.7% of the patients. The enteroscopic
findings were consistent with the VCE findings in 73.3%
Table 2 Demographic data, details of the endoscopic procedures, endoscopic findings, and clinical outcomes according











Details (n = 84) (n = 21) (n = 14) (n = 18) (n = 8)
n (%) n (%) n (%) n (%) n (%)
Age (years) 61.8 ± 18.0 81.0 ± 18.3 50.4 ± 12.7 47.5 ± 14.5 55.7 ± 15.5
Sex: male 51 (60.7) 6 (28.6) 9 (64.5) 5 (27.8) 4 (50.0)
Route: antegrade 60 (71.4) 18 (85.7) 11 (78.6) 16 (88.9) 7 (87.5)
Areas of interest achieved 61 (72.6) 20.0 (95.2) 11 (78.6) 18 (100) 7 (87.5)
Findings
Negative 37 (44.0) 7 (33.3) 3 (21.4) 6 (33.3) 5 (62.5)
Positive 48 (56.0) 14 (66.7) 11 (78.6) 12 (66.7) 3 (37.5)
Erosions 13 (15.5) 3 (14.3) 11 (78.6) 3 (16.7) 1 (12.5)
Ulcers 14 (16.7) 3 (14.3) 6 (42.9) 3 (16.7) 0 (0.0)
Stricture 0 (0.0) 2 (9.5) 4 (28.6) 0 (0.0) 0 (0.0)
Angiodysplasia 4 (4.8) 1 (4.8) 0 (0.0) 0 (0.0) 0 (0.0)
Polyp 1 (1.2) 4 (19.0) 0 (0.0) 3 (16.7) 0 (0.0)
Mass 8 (9.5) 2 (9.5) 1 (7.1) 0 (0.0) 1 (12.5)
Non-specific erythematous mucosa 5 (6.0) 2 (9.5) 9 (64.2) 7 (38.9) 1 (12.5)
Blood stain 4 (4.8) 0 (0.0) 1 (7.1) 0 (0.0) 0 (0.0)
Atrophic villi 0 (0.0) 0 (0.0) 1 (7.1) 0 (0.0) 0 (0.0)
Dieulafoy’s lesion 5 (6.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Diverticulum 4 (4.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Varix 2 (2.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Hemangioma 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Lymphangiectasia 7 (8.3) 2 (9.5) 3 (21.4) 1 (5.6) 1 (12.5)
Failure 7 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5)
Therapeutic interventions performed 11 (13.1) 5 (23.8) 0 (0.0) 0 (0.0) 0 (0.0)
Clinical conclusion 37 (44.0) 7 (33.3) 3 (21.4) 6 (33.3) 5 (62.5)
Negative finding
Incidental finding 11 (13.1) 3 (14.3) 3 (21.4) 3 (16.7) 1 (12.5)
Associated positive finding 11 (13.1) 1 (4.8) 4 (28.6) 5 (27.8) 1 (12.5)
Definitive diagnosis 25 (29.8) 10 (47.6) 7 (50.0) 4 (22.2) 1 (12.5)
Diagnostic yield 36 (42.9) 11 (52.4) 13 (78.6) 8 (50.0) 2 (25.0)
Clinical success 35 (41.7) 11 (52.4) 10 (71.4) 7 (38.9) 3 (37.5)
Minor complications 9 (10.5) 3 (14.3) 1 (7.1) 0 (0.0) 2 (25.0)
Time to enteroscopy (days) 49.3 N/A N/A N/A N/A
VCE done 51 (60.7) 11 (52.4) 2 (14.3) 3 (16.7) 0 (0.0)
Abbreviations: GI Gastrointestinal, VCE Video capsule enteroscopy, N/A Not available.
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36.1% of the patients with negative enteroscopic find-
ings (data not shown).
Occult GI bleeding
Twenty-one procedures were performed to investigate
occult GI bleeding. The mean age of these patients was81.0 ± 18.3 years, which was higher than in the other
groups. The most common enteroscopic findings were
erosions and ulcers (28.6%), followed by tumors (9.5%)
and angiodysplasia (4.8%). No Dieulafoy’s lesions were
found in this group. The areas of interest were achieved
in approximately 95.2% of the procedures The diagnostic
yield of SBE for occult GI bleeding was 52.4%. However,
Figure 1 Complications of single balloon enteroscopy.
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tified in approximately 47.6% of the patients. Therapeutic
interventions were performed during 5 procedures and
were successful in all cases. The clinical success rate in this
group was 50%. Both VCE and SBE were performed in
52.4% of the patients. The enteroscopic findings were con-
sistent with the VCE findings in all of the patients with
positive enteroscopic findings and in 12.5% of the patients
with negative enteroscopic findings (data not shown).
Abnormalities on imaging studies
The diagnostic yield of SBE was 25% in the patients who
presented with abnormalities on imaging scans. The most
common enteroscopic findings were erosions (12.5%) and
tumors (12.5%). However, the definitive causes of the ab-
normalities on the imaging scans remained unidentified in
approximately 75% of the patients. Of the 8 patients, 4 who
had diffuse or long-segment thickening of the small bowel
on CT scans had negative SBE findings (data not shown),
whereas 1 who had a bowel mass and 1 who had a focal
area of bowel wall thickening on imaging scans had positive
SBE findings.
Abdominal pain
Of the 14 patients who presented with abdominal pain,
7 underwent imaging studies. The diagnostic yield of
SBE was 78.6%, and the most common findings were
erosions (78.6%) and ulcers (42.9%), followed by stric-
tures (28.6%), of which 5 of 7 patients were diagnosed
with Crohn’s disease (data not shown). A tumor was
identified as the cause of the abdominal pain in only 1
patient (7.1%) in this group.
Chronic diarrhea
A diagnostic yield of 50.0% was obtained in 9 of 18 patients.
The most common enteroscopic finding was nonspecific
changes (38.9%), followed by erosions and ulcers (33.4%).
Mass lesions were not the cause in this group. The defini-
tive diagnoses, as determined by histopathological exami-
nation, were eosinophilic enteritis, lymphoma, Crohn’s
disease, and Capillaria philippinensis infestation.
Therapeutic interventions
Therapeutic interventions were performed in 16 patients
(11.0%) with overt or occult GI bleeding (11 procedures in
patients with overt GI bleeding and 5 in patients with oc-
cult GI bleeding). The therapeutic interventions involved
epinephrine injection in 10 patients, hemostatic clip appli-
cation in 9, argon plasma coagulation (APC) in 9,
polypectomy in 4, and Histoacryl® injection in 1. The tech-
nical success rate was 100%, with an overall clinical success
rate of 93.7%. The therapeutic intervention failed only in 1
patient. That patient had undergone pylorus-preserving
pancreaticoduodenectomy and presented with overt GIbleeding a few days after surgery. Active bleeding from an
anastomotic site was noted during SBE and was initially
stopped by APC. However, the patient experienced recur-
rent bleeding 1 day later and was finally treated surgically.
Complications
Complications were reported in 11.7% of the cases in
the present study. All were classified as minor complica-
tions, as depicted in Figure 1, and most involved only
abdominal discomfort and minimal small bowel mucosal
trauma, allowing the patients to be discharged on the
same day. Neither perforation nor acute pancreatitis was
observed in this study.
Discussion
One-third of the patients in this study were aged >70 years.
All of the patients tolerated the procedures well without
any significant complications. These findings suggest that
SBE is a safe and effective procedure even in elderly pa-
tients. Most of the SBE procedures performed in the
present study were performed in an antegrade fashion. The
failure rate of SBE in this study was 5.5%, which is lower
than the 10% failure rate reported by Upchurch et al. [3].
The rate of total enteroscopy in this study was 6.2%, similar
to the approximately 0–22% range for SBE reported else-
where [9-13]. However, these numbers are much lower
than the 18–66% rate of total enteroscopy in many reports
using DBE. Many experts in balloon-assisted enteroscopy
believe that the success of this method depends on the
technique used during the pull phase of enteroscopy. How-
ever, the area of interest was achieved in approximately
80.7% of procedures, and these procedures yielded an over-
all diagnosis in approximately 42.8% of cases, which is
similar to the rates of 37–61% reported elsewhere for SBE
[3,5,10,11,13,14]. In addition, this result was comparable
with those of DBE studies that reported diagnostic yields of
approximately 43–72% [5,11]. However, some question re-
mains as to whether the technically appreciated end point
of complete small bowel visualization is preferable to the
more clinically relevant end point of diagnostic yield.
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at this time and requires further study. The therapeutic yield
was lower in this study than in other studies from Europe
and America [3-6] that reported therapeutic yields as high
as 24–42%, with a bleeding recurrence rate of 20%. How-
ever, some of the procedures done in these Western studies,
including biopsy and endoscopic tattooing, might have
greatly affected the total therapeutic procedure and yield.
Most of the patients who underwent therapeutic treatment
in the present study, all of whom presented with GI bleed-
ing, achieved initial hemostasis. Therefore, the therapeutic
yield for GI bleeding in this study would be 14.6%.
The aim of the present study was to determine the per-
formance of SBE according to the patients’ clinical mani-
festations. The most common indication for performing
enteroscopy in the present study was GI bleeding, as in
previous studies. Moreover, the highest diagnostic yield
(78.6%) was found in the patients who presented with ab-
dominal pain associated with inflammatory bowel diseases
and mass lesions. The diagnostic yield was only 42.9% in
the overt GI bleeding group and 54.0% in the occult GI
bleeding group. These results were not consistent with
those of previous Western studies, which reported diag-
nostic yields of as high as 78% in patients presenting with
GI bleeding [4,5]. In addition, the most common cause of
bleeding was erosions and ulcers; this was similar to the
findings of other Asian studies but different from those of
the Western studies, in which angiodysplasia was the most
common finding. Therefore, we hypothesized that the dif-
ference in diagnostic yield might be related to the different
etiologies of GI bleeding. We suspect that a prolonged time
interval between clinical presentation and enteroscopy, i.e.,
time to enteroscopy, could produce false-negative findings.
Therefore, we determined the time to enteroscopy in this
study, which was 49.3 ± 104.9 days overall. The reason for
this prolonged time to enteroscopy was related to our
health system. The patients who were referred for SBE in
our hospital (a university-based tertiary care center located
in the central part of Thailand) came from all over the
country. In general, it takes some time to arrange for such
referrals arrangement. However, in the patients with overt
GI bleeding, the time interval between the onset of bleed-
ing and the day on which enteroscopy was performed did
not differ significantly according to whether a definitive
diagnosis was achieved (p = 0.08). Therefore, the time to
enteroscopy might not be directly related to the diagnostic
yield. The previously mentioned hypothesis would also
suggest that the low diagnostic rate in this study might be
related to the etiology of the bleeding itself, which was
most frequently found to be erosions and ulcers. However,
the time to enteroscopy in this study was rather prolonged,
which may have allowed the lesions to heal and disappear.
Furthermore, the therapeutic interventions performed in
the GI bleeding groups showed very high success rates.Therefore, patients who present with overt or occult GI
bleeding with concurrent blood loss should undergo
enteroscopy rather than other modalities, as the diagnostic
yield and therapeutic impact are equal to those of VCE.
Enteroscopy rather than VCE should be the initial proced-
ure particularly for patients who present with overt GI
bleeding, which carries greater potential for therapeutic
intervention. The etiology of GI bleeding is also a source of
discrepancy. Angiodysplasia has been reported as the most
common lesion found in many Western studies, occurring
in 6–43% of all cases [8-15]. However, we detected this le-
sion in only 3.4% of the cases, similarly to many other
Asian studies. In our opinion, this may be because of the
difference in ethnicity. Dieulafoy’s lesion was reported to be
the source of overt GI bleeding in 3.5% of the cases in an
Australian study [16]; most of the lesions were located in
the proximal jejunum, with a 20% bleeding recurrence rate
during 12.5 months of follow up. The present study found
Dieulafoy’s lesions as the cause of the GI bleeding in 5 cases
(6%); all of these lesions were located in the mid- to distal je-
junum, and all associated therapeutic procedures were suc-
cessful without any recurrence of bleeding. Half of the mass
lesions found in this study were GI stromal tumors; lymph-
oma accounted for one-third of the patients, and only 1 case
of intestinal adenocarcinoma was found. Most of the lesions
were located in the jejunum. Our results were comparable
to those of a meta-analysis of the performance of DBE by
Xin L et al. in 2011 [17]. In that study, the most common
indication indication for enteroscopy was suspected mid-GI
bleeding (62.5%), followed by symptoms/signs only (7.9%),
small-bowel obstruction (5.8%), and Crohn’s disease (5.8%).
The pooled detection rates were 68.1%, 68.0%, 53.6%, 63.4%,
and 85.8% for overall, suspected mid-GI bleeding, symp-
toms/signs only, Crohn’s disease, and small-bowel obstruc-
tion, respectively. Inflammatory lesions (37.6%) and vascular
lesions (65.9%) were the most common findings in patients
with suspected mid-GI bleeding in Eastern and Western
countries, respectively. The pooled rate of total enteroscopy
by combined or antegrade-only approaches was 44.0%. GI
bleeding was also the most frequent indication in the
present study, but our detection rate for GI bleeding was
lower. However, the causes of bleeding in this study were
predominantly inflammatory rather than vascular lesions,
similar to those in other reports from Eastern counties. The
rate of total enteroscopy in this study was very low.
In patients with chronic diarrhea, a definitive diagnosis
was obtained in only 22% of the cases with diffuse histo-
pathological signs. Therefore, enteroscopy might not be
effective in this diagnostic group. The highest diagnostic
yield in the present study was for the patients who
presented with abdominal pain. Most of these patients
were diagnosed with Crohn’s disease. In the group with
abnormal imaging study findings, enteroscopy was more
effective in the patients with focal lesions than those
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SBE findings were negative in most of the patients with
diffuse small bowel thickening; therefore, other imaging
methods such as VCE might be more useful in such cases.
The major complications reported previously, such as per-
foration and acute pancreatitis, were not observed in this
series; only minor complications were detected. The limi-
tations of the present study include the retrospective study
design, which might have allowed the inclusion of inaccu-
rate procedure data, such as the insertion depth estimates.
Another limitation is the small population in some groups
especially those with abnormalities on imaging studies,
chronic diarrhea, and chronic abdominal pain, which do
not provide adequate data for comparative analysis. There-
fore, a prospective study design would be appropriate for
future research to validate our findings.
Conclusions
The data obtained from this series are comparable to the
results previously reported for DBE and demonstrate that
SBE is a safe and effective procedure for imaging and
performing therapeutic interventions in the small bowel.
The clinical manifestations for which SBE provided good
diagnostic yields were chronic abdominal pain, occult/overt
GI bleeding, and focal abnormalities on imaging scans.
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